Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Inventor:
Russo; Angelo
Address:
Bethesda, MD
No. of patents:
7
Patents:












Patent Number Title Of Patent Date Issued
7153866 Use of tempol for the treatment of Li-Fraumeni syndrome and ataxia telangiectasia December 26, 2006
The present invention provides a method for the prophylactic and therapeutic treatment of cancer. The method comprises administering to an animal, preferably a mammal, more preferably a human, at risk for developing a cancer or having a cancer a nitroxide or a prodrug thereof, wherei
6573720 Resonant structure for spatial and spectral-spatial imaging of free radical spin probes using ra June 3, 2003
A radiofrequency (RF) coil design, suitable for detecting time domain electron paramagnetic resonance (EPR) responses from spin probes after pulsed excitation using radiofrequency irradiation (60-400 MHz), is configured in an array of numerous surface coils of appropriate diameters c
5840759 Use of nitric oxide releasing compounds to protect noncancerous cells from chemotherapeutic agen November 24, 1998
The present invention provides a method for sensitizing hypoxic cells in a tumor to radiation, wherein nitric oxide is delivered to target hypoxic cells through the administration of a nitric oxide-containing compound that spontaneously releases nitric oxide under physiological condition
5837736 Nitric oxide-releasing compounds to sensitive cancerous cells to chemotherapeutic agents November 17, 1998
The present invention provides a method for sensitizing hypoxic cells in a tumor to radiation, wherein nitric oxide is delivered to target hypoxic cells through the administration of a nitric oxide-containing compound that spontaneously releases nitric oxide under physiological condition
5814667 Use of nitric oxide-releasing compounds as hypoxic cell radiation sensitizers September 29, 1998
The present invention provides a method for sensitizing hypoxic cells in a tumor to radiation, wherein nitric oxide is delivered to target hypoxic cells through the administration of a nitric oxide-containing compound that spontaneously releases nitric oxide under physiological condition
5789447 Nitric oxide releasing compounds as protective agents in ischemia reperfusion injury August 4, 1998
The present invention provides a method for treating oxygen free radical induced tissue damage associated with ischemia reperfusion injury, wherein nitric oxide is delivered to target cells/tissues through the administration of a nitric oxide-containing compound that spontaneously re
5650442 Use of nitric oxide releasing compounds as hypoxic cell radiation sensitizers July 22, 1997
The present invention provides a method for sensitizing hypoxic cells in a tumor to radiation, wherein nitric oxide is delivered to target hypoxic cells through the administration of a nitric oxide-containing compound that spontaneously releases nitric oxide under physiological condition










 
 
  Recently Added Patents
Human embryonic stem cell methods and PODXL expression
Method and apparatus for supporting delivery, sale and billing of perishable and time-sensitive goods such as newspapers, periodicals and direct marketing and promotional materials
Video reproducing apparatus and video reproducing method
Method and apparatus for blind signal extraction
Modular connector for touch sensitive device
Switching device and electronic apparatus using the same
Semiconductor memory device and method for driving the same
  Randomly Featured Patents
Reinforcement device for vehicle
Isolated phase bus duct joint assembly
Interconnect supported fuel cell assembly and preform
Intelligently representing files in a view
Logarithmic amplifier gain stage
System for executing SIMD instruction for real/complex FFT conversion
Apparatus and method for generating a delayed clock signal
Stem booster
Developing cartridge for electrophotographic image forming apparatus
Solution formulations of sirolimus and its analogs for CAD treatment